Baseline characteristics of a phase III randomized controlled trial of acupuncture for chemotherapy-induced peripheral neuropathy (ACT trial)

Authors
Category Primary study
ConferenceJournal of clinical oncology
Year 2026
This article has no abstract
Epistemonikos ID: ee7745c57ff400282c65ede96f1aca82cddf2a66
First added on: Jun 20, 2026